K. Klebs

1.5k total citations
10 papers, 608 citations indexed

About

K. Klebs is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, K. Klebs has authored 10 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 2 papers in Cognitive Neuroscience. Recurrent topics in K. Klebs's work include Neuroscience and Neuropharmacology Research (8 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Ion channel regulation and function (4 papers). K. Klebs is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Ion channel regulation and function (4 papers). K. Klebs collaborates with scholars based in Switzerland, Germany and Canada. K. Klebs's co-authors include Markus Schmutz, V. Baltzer, Gilles Sansig, Herman van der Putten, H.-R. Olpe, Hans Allgeier, Graham E. Fagg, Henk van Riezen, Roland Heckendorn and A. Vassout and has published in prestigious journals such as Journal of Neuroscience, Cellular and Molecular Life Sciences and European Journal of Neuroscience.

In The Last Decade

K. Klebs

10 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Klebs Switzerland 9 499 246 139 132 62 10 608
Rita Jakus Hungary 13 509 1.0× 177 0.7× 356 2.6× 342 2.6× 41 0.7× 17 867
S.M. Sorensen United States 10 485 1.0× 258 1.0× 114 0.8× 117 0.9× 15 0.2× 15 676
L.G. Stark United States 17 731 1.5× 282 1.1× 176 1.3× 333 2.5× 19 0.3× 52 942
Helen L. Rowley United Kingdom 13 468 0.9× 173 0.7× 129 0.9× 235 1.8× 20 0.3× 18 678
Rodolfo Silveira Uruguay 15 479 1.0× 177 0.7× 212 1.5× 23 0.2× 39 0.6× 26 779
Wolfgang L�scher Germany 16 621 1.2× 279 1.1× 88 0.6× 301 2.3× 11 0.2× 24 846
Sam Castellani United States 12 316 0.6× 178 0.7× 52 0.4× 84 0.6× 74 1.2× 15 472
Brenda K. Colasanti United States 17 413 0.8× 157 0.6× 174 1.3× 84 0.6× 47 0.8× 45 704
A. Scotti de Carolis Italy 16 678 1.4× 279 1.1× 250 1.8× 116 0.9× 18 0.3× 63 939
J.W. Boja United States 12 1.3k 2.7× 852 3.5× 111 0.8× 83 0.6× 101 1.6× 24 1.5k

Countries citing papers authored by K. Klebs

Since Specialization
Citations

This map shows the geographic impact of K. Klebs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Klebs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Klebs more than expected).

Fields of papers citing papers by K. Klebs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Klebs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Klebs. The network helps show where K. Klebs may publish in the future.

Co-authorship network of co-authors of K. Klebs

This figure shows the co-authorship network connecting the top 25 collaborators of K. Klebs. A scholar is included among the top collaborators of K. Klebs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Klebs. K. Klebs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kaupmann, Klemens, John F. Cryan, Petrine Wellendorph, et al.. (2003). Specific γ‐hydroxybutyrate‐binding sites but loss of pharmacological effects of γ‐hydroxybutyrate in GABAB(1)‐deficient mice. European Journal of Neuroscience. 18(10). 2722–2730. 152 indexed citations
2.
Sansig, Gilles, Trevor J. Bushell, Vernon R. J. Clarke, et al.. (2001). Increased Seizure Susceptibility in Mice Lacking Metabotropic Glutamate Receptor 7. Journal of Neuroscience. 21(22). 8734–8745. 165 indexed citations
3.
Klebs, K., et al.. (1992). Blockade of GABAB receptors accelerates amygdala kindling development. Cellular and Molecular Life Sciences. 48(8). 748–751. 16 indexed citations
4.
Schmutz, Markus, K. Klebs, A. Vassout, et al.. (1990). The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(1). 61–66. 126 indexed citations
5.
Bernasconi, R., Christian Marescaux, M. Vergnes, et al.. (1988). Evaluation of the anticonvulsant and biochemical activity of CGS 8216 and CGS 9896 in animal models. Journal of Neural Transmission. 71(1). 11–27. 8 indexed citations
6.
Schmutz, Markus, K. Klebs, & V. Baltzer. (1988). Inhibition or enhancement of kindling evolution by antiepileptics. Journal of Neural Transmission. 72(3). 245–257. 62 indexed citations
7.
Olpe, H.-R., K. Klebs, A. Glatt, et al.. (1987). Cholinomimetics induce θ rhythm and reduce hippocampal pyramidal cell excitability. European Journal of Pharmacology. 142(2). 275–283. 31 indexed citations
8.
Bennett, Debra A., Douglas E. Wilson, Carl A. Boast, et al.. (1987). Pharmacological characterization of CGS 17867A as a benzodiazepine receptor agonist devoid of limiting behavioral effects. Drug Development Research. 11(3-4). 219–233. 10 indexed citations
9.
Schmutz, Markus, Marianne Klein, K. Klebs, et al.. (1985). Pharmacological and neurochemical aspects of kindling. Journal of Neural Transmission. 63(2). 143–155. 13 indexed citations
10.
Glatt, A., et al.. (1979). Epileptic phenomena induced in the cat by the antidepressants maprotiline, imipramine, clomipramine, and amitriptyline.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(3). 485–97. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026